- Home
- MDCX
as 10-29-2025 9:37am EST
Stocks
Medicus Pharma Ltd is a clinical-stage holding company focused on investing in and accelerating novel life sciences and bio-technology companies through FDA-approved clinical trials. The Company focuses on meeting the unmet need to improve patient safety and efficacy.
| Founded: | 2008 | Country: | United States |
| Employees: | N/A | City: | W. CONSHOHOCKEN |
| Market Cap: | 50.8M | IPO Year: | N/A |
| Target Price: | $23.50 | AVG Volume (30 days): | 352.6K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 2 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -1.37 | EPS Growth: | N/A |
| 52 Week Low/High: | $1.79 - $8.94 | Next Earning Date: | 11-22-2025 |
| Revenue: | N/A | Revenue Growth: | N/A |
| Revenue Growth (this year): | N/A | Revenue Growth (next year): | N/A |
Latest Medicus Pharma Ltd. Common Stock News
MDCX Breaking Stock News: Dive into MDCX Ticker-Specific Updates for Smart Investing
ACCESS Newswire
7 days ago
Medicus Pharma Ltd. Announces First Patient Treated in United Arab Emirates (UAE) Sknjct-004 Phase 2 Clinical Study to Non-Invasively Treat Basal Cell Carcinoma (BCC) of the Skin
ACCESS Newswire
15 days ago
Three Biotech Companies Redefining Value Creation Through Dual Strategies
ACCESS Newswire
15 days ago
The Vanderbilt Report: Medicus Pharma Ltd Built Three Separate Billion-Dollar Bets
ACCESS Newswire
16 days ago
Medicus Pharma Ltd. to Present at The Maxim Growth Summit 2025
ACCESS Newswire
22 days ago
Medicus Pharma Ltd. to Present at the Family Office Summit in Dubai, UAE
ACCESS Newswire
2 months ago
Medicus Pharma Ltd. Provides Update on United Arab Emirates (UAE) SKNJCT-004 Phase 2 Clinical Study to Non-Invasively Treat Basal Cell Carcinoma of the Skin (BCC)
Newsfile
2 months ago
Medicus Pharma Ltd. Provides Update on Doxorubicin Containing Novel Microneedle Array (D-MNA) Clinical Development Program for the Treatment of Basal Cell Carcinoma (BCC) of the Skin and Reports Second Quarter 2025 Financial Highlights
Newsfile
4 months ago
Medicus Pharma Ltd Announces a Definitive Agreement to Acquire Antev Ltd. UK
Compare MDCX vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "MDCX Medicus Pharma Ltd. Common Stock - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.